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Abstract
Pseudomonas aeruginosa is an environmental pathogen that can cause severe infections in
immunocompromised patients. P. aeruginosa infections are typically treated with multiple
antibiotics including tobramycin, ciprofloxacin, and meropenem. However, antibiotics do not
always entirely clear the bacteria from the infection site, where they may remain virulent.
This is because the effective antibiotic concentration and diffusion in vitro may differ from
the in vivo environment in patients. Therefore, it is important to understand the effect of non-
lethal sub-inhibitory antibiotic concentrations on bacterial phenotype. Here, we investigate if
sub-inhibitory antimicrobial concentrations cause alterations in bacterial virulence factor
production using pyocyanin as a model toxin. We tested this using the aforementioned anti-
biotics on 10 environmental P. aeruginosa strains. Using on-the-spot electrochemical
screening, we were able to directly quantify changes in production of pyocyanin in a mea-
surement time of 17 seconds. Upon selecting 3 representative strains to further test the
effects of sub-minimum inhibitory concentration (MICs), we found that pyocyanin production
changed significantly when the bacteria were exposed to 10-fold MIC of the 3 antibiotics
tested, and this was strain specific. A series of biologically relevant measured pyocyanin
concentrations were also used to assess the effects of increased virulence on a culture of
epithelial cells. We found a decreased viability of the epithelial cells when incubated with bio-
logically relevant pyocyanin concentrations. This suggests that the antibiotic-induced viru-
lence also is a value worth being enclosed in regular testing of pathogens.
Introduction
The rapid emergence of antibiotic resistance is endangering the efficacy of antibiotics [1]. The
susceptibility profile of bacterial pathogens provides valuable information to prescribe the
most efficient antibiotic treatment. While it is known that the antimicrobial impact indeed is
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not an ‘all or none’ effect, treatment without antimicrobial susceptibility information may con-
tribute to recurring and chronic infections [2–4]. The effect of sub-inhibitory antimicrobial
concentrations on bacterial virulence is a field that is not intensively studied. This calls for
increased efforts to understand the implication of sub-inhibitory concentrations of antimicro-
bials on bacterial virulence profiles.
Pseudomonas aeruginosa is an opportunistic pathogen listed by the World Health Organi-
zation as one of the three pathogens that causes severe infections and high mortality in hospital
patients [5–7]. Current antibiotic treatment for P. aeruginosa infections are classically placed
amongst the fluoroquinolones (e.g. ciprofloxacin), the beta-lactams (e.g. meropenem), and the
aminoglycosides (e.g. tobramycin, gentamicin), with polymyxins being used as a last resort
option [8,9]. Antibiotic treatment has inevitably led to evolution of many antibiotic-resistant
mechanisms within this pathogen, making it difficult to treat in the clinic.
P. aeruginosa is known for its ability to produce numerous virulence factors that play an
important role in the early phases of bacterial host colonization [10]. One of these virulence
factors is pyocyanin, a quorum-sensing regulated toxin that plays an important role in killing
host epithelial cells, and has an antagonistic effect towards other bacterial species [11,12]. Pyo-
cyanin has been studied concerning human infections; however, its role and secretion pattern
in environmental strains of P. aeruginosa has not been investigated. The toxicity exerted by
pyocyanin is due to their ability to enter the cell interior and use oxygen as an electron accep-
tor subsequently generating reactive oxygen species (ROS) (e.g. hydrogen peroxide) and
induce oxidative stress to the cell. Studies have shown that pyocyanin exerts minor toxic events
in the range of 5–10 mg/L in lung epithelial cells (L-132) [13]. Additionally, Saunders et al.
suggest that pyocyanin plays an important role in the metabolism of P. aeruginosa biofilm due
to its participation in charge transfer processes [14].
Traditionally, virulence molecules are determined by extensive laboratory processing,
including chemical and mechanical sample pretreatment, chemical extraction and often com-
plicated and time-consuming signal identification procedures [15]. Such laboratory-intensive
protocols often lack precision and are difficult to conduct for high-throughput screenings [4].
For example, pre-treatment often leads to loss of sample quality during sample preparation
steps. Therefore, new technologies for rapid, high-throughput and sensitive screening of viru-
lence factors are needed. Direct on-the-spot screening of pyocyanin in un-treated samples
using electrochemical sensors is an emerging field that is gaining increased attention for its
simplicity and rapid quantification [16–19].
Here, we utilize the high-throughput electrochemical method that does not require sam-
ple preparation and allows for the identification and quantification of pyocyanin in 17 sec-
onds. We screened 10 different P. aeruginosa environmental strains and the laboratory
strain PAO1 for their pyocyanin activity in response to treatment with antibiotics from the
three core classes, i.e. ciprofloxacin, meropenem, and tobramycin at varying concentrations.
The quantification of pyocyanin enabled by this technique revealed that sub-inhibitory anti-
biotic concentrations induce increased pyocyanin secretion. Crucially, the increased pyo-
cyanin production is in a range that has been reported to be detected in patients with P.
aeruginosa infections [12,20,21]. Finally, we found that this increase in pyocyanin produc-
tion has an antagonistic effect on epithelial cells. These findings suggest that patients receiv-
ing antibiotic treatment could experience side effects such as worsened pathogenic
virulence. Similarly, due to the effect of antibiotic pollution in the environment [22], our
results suggest that environmental strains of P. aeruginosa, an important source of infection
in critical care units and cystic fibrosis patients [23] could also experience increased
virulence.
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The Pseudomonas aeruginosa (Pae) strains used in the present study are environmental isolates
from soil, sediment, and water (S1 Table) which have previously been published [24]. PAO1
was used as a reference strain.
Determining the minimum inhibitory concentrations
Minimum inhibitory concentrations (MIC) for ciprofloxacin, tobramycin and meropenem
were obtained using E-test strip diffusion and micro broth dilution methods. E-test plastic
strips (Liofilchem, Italy) that have a predefined gradient of antibiotic concentration [25]. A 0.5
McFarland standard suspension was inoculated onto Mueller-Hinton agar plates. Up to four
E-test strips were placed on each plate following the manufacturer’s instructions (Liofilchem,
Italy). The concentrations measured were: ciprofloxacin: 0.002–32 μg/mL, tobramycin: 0.016–
256 μg/mL, and meropenem: 0.002–32 μg/mL. For the micro broth dilution method, we
diluted overnight cultures of P. aeruginosa isolates (1:50) in fresh LB media, which we allowed
to grow to exponential phase (OD600 = 0.4) and then diluted to 2–8 105 colony forming units
(CFU) per mL in 96-well polypropylene plates with or without series of concentrations of the
three antibiotics tested. The plates were incubated at 37˚C and after 20–24 hours the highest
concentration where no visible growth was observed was noted as the MIC value. The 10x-sub
MIC values used in the present study for the three tested strains were the following: PAO1
(Cipro = 0.0125 μg/mL; Tobra = 0.0125 μg/mL, Mero = 0.05 μg/mL), Pae85 (Cipro =
0.0125 μg/mL; Tobra = 0.1 μg/mL, Mero = 0.025 μg/mL) and Pae112 (Cipro = 0.025 μg/mL;
Tobra = 0.05 μg/mL, Mero = 0.025 μg/mL). The applied standardized MIC protocol is based
on Wiegand et al. 2008 [26].
Electrochemical screening of pyocyanin
Pyocyanin is a redox-active molecule possible to detect directly with electrochemical sensors
as previously described [17,18]. All measurements were conducted by pipetting 50 μL of the
sample on a single-use disposable sensor (GPH110, Metroohm, Denmark) operated by a
potentiostat (EmstatBlue, PalmSens, Netherlands) using a square voltammetry procedure mea-
suring from -0.6 V to 0.0 V at a step potential of 0.05 and a total run-time of 17 seconds. First,
we generated calibration curves for pyocyanin by measuring three independent serial dilutions
of pure pyocyanin (P0046, Merck, Denmark) prepared in lysogeny broth (LB) media ranging
between 1.5 μM and 24 μM. To measure the concentrations of pyocyanin produced by the ten
environmental bacterial strains and strain PAO1, we grew fresh bacterial cultures in round
bottom glass tubes containing 3 ml LB for 24 hours at 37˚C and shaking at 180 rpm. Then, we
diluted the cultures to starting inoculum OD600 of 0.01 in round bottom glass tubes contain-
ing 3 ml LB and allowed them to grow for another 24 hours to assure stationary phase for all
different isolates before 50 μL was taken for measurements. The experiments were conducted
in five biological replicates.
Determining the pyocyanin production in presence of antibiotics
Selected environmental strains Pae85 and Pae112 and PAO1 were grown for 24 hours after
which the cultures were diluted to an optical density (OD600 nm) of 0.01 and allowed to grow
until OD 600 nm of 0.1–0.2 was reached. At this stage, 50 μL samples were taken for measuring
the concentration of pyocyanin. A small volume (2 mL) of each of the cultures was taken into
3 separate tubes and antibiotics at concentrations below the MIC was added. The bacteria with
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and without antibiotics were allowed to grow for 24 hours, at 37˚C and shaking at 180 rpm.
After the 24 hours of incubation, 50 μL of each of the cultures with and without antibiotics for
each of the strains was taken for quantification. The OD600 nm for each of the isolates was
measured and used for normalization of the production of pyocyanin. To confirm that there
was no chemical interference between the antibiotic and the virulence factor that would affect
the measurements, samples of a constant concentration of pyocyanin spiked with each of the
three antibiotics were measured (Cipro = 0.125 μg/mL; Tobra = 0.25 μg/mL, Mero = 1 μg/
mL). Additionally, different concentrations of tobramycin were added to the supernatant of
PAO1 and measured electrochemically. The electrochemical measurements of pyocyanin did
not change (S1 Fig).
Determining the effect of virulence factor on epithelial cells
To evaluate the degree of toxicity of pyocyanin production on a potential host, we assessed the
cytotoxicity of pyocyanin produced in the supernatant of strain PAO1 on HaCaT cells–human
immortalized keratinocytes that are the predominant human cell types of the epidermis [27].
HaCaT cells [28] were provided by Bispebjerg Hospital, Denmark. We obtained PAO1 super-
natant from an overnight culture that we centrifuged and filtered so that no viable cells or cell
debris was present. Sterility of the supernatant after filter purification was confirmed by plating
100 μL of the supernatant on Pseudomonas isolation agar plates followed by 24 hours incuba-
tion at 37˚C. Cytotoxicity was determined using an assay previously described [29]. Briefly, the
assay relies on the ability of viable cells to convert the novel tetrazolium salt MTS [(3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]
into a soluble formazan product, and will hereafter be referred to as MTS cytotoxicity assay.
Absorbance at 490 nm is measured and is directly proportional to the viability of the cells. Ker-
atinocytes were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with glutamax
(Thermofisher, Denmark), supplemented with 100 U/mL penicillin/streptomycin and 10%
heat-inactivated fetal bovine serum (FBS GIBCO; Thermofisher, Denmark). Cells were seeded
at a concentration of 15 × 104 per well in a sterile, flat-bottom 96-well polystyrene plates for 24
hours and then carefully washed with phosphate-buffered saline (PBS) without Ca+2 and
Mg+2. Pyocyanin (CAS:85-66-5, Merck, Germany) in DMEM at 5 different concentrations
and PAO1 supernatant was added to each well. The plates were incubated for 24 hours in a
humidified 5% CO2 atmosphere at 37˚C, after which 20 μL of MTS -phenazine methosulfate
(PMS) solution was added, and the plate was further incubated for 2 hours for colour develop-
ment. Absorbance at 490 nm was measured using the Synergy HT microplate reader. For via-
bility controls and baseline correction, 1% Triton X-100 (0% viability), untreated cells (100%
viability), and cell-free DMEM were used. Additionally, pyocyanin and PAO1 supernatant in
DMEM at the highest concentration were also measured for the possibility of colour interfer-
ence. The percent viability was expressed as the concentration of pyocyanin standard and
from PAO1 supernatant that reduces cell viability by 50%.
Statistical analysis
For the statistical analysis of the data, GraphPad Prism version 7.00, GraphPad Software, La
Jolla California, USA was used. For the overall pyocyanin production in all the strains tested,
we used a one-way ANOVA followed by a Tuckey post hoc test to investigate differences
between treatments. For changes in pyocyanin production in presence of antibiotics, we used
two statistical comparisons. For multiple comparisons, we calculated adjusted P values (adj-P)
using one-way ANOVA with Bonferroni correction and for single treatment analysis, we used
a series of paired t-tests.
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Results
Quantification of pyocyanin produced by environmental strains
The characteristic electrochemical peak of pyocyanin was found at ~ -0.29 V using square
wave voltammetry (SWV) as displayed in Fig 1A. Increasing pyocyanin concentrations result
in higher peak heights as denoted by the inset where the concentration is plotted as function of
the current. A linear fit of the data reveals linearity of R2 = 0.997. The calibration curve was
used to convert the current measurements of the culture samples into pyocyanin concentra-
tion. A constant pyocyanin concentration was measured with the presence of tobramycin,
Fig 1. Electrochemical detection of pyocyanin. (a) Square wave voltammogram of pyocyanin in Lysogeny Broth
media. Inset shows a standard curve with extracted peak heights from square wave voltammograms as a function of
pyocyanin concentration. (b) Electrochemical pyocyanin detection with and without the presence of all three
antibiotics in the sample (Means with SD from 3 replicates).
https://doi.org/10.1371/journal.pone.0248014.g001
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ciprofloxacin and meropenem, confirming that the antibiotics do not affect the electrochemi-
cal signal of pyocyanin (Fig 1B). The potentials at which other relevant molecules undergo
redox-reactions do not overlap with the peak potential of pyocyanin as demonstrated by previ-
ous electrochemical studies of pyoverdine, 4-hydroxy-2-heptylquinoline (HHQ), 2-heptyl-
3,4-dihydroxyquinoline (PQS), phenazine-1-carboxylic acid and 5-methylphenazine-1-car-
boxylic acid [16,19,30]. Thus, the detection window of pyocyanin in LB is not in conflict with
the detection window of other relevant molecules.
The level of heterogeneity in pyocyanin production was investigated using electrochemical
measurements. The pyocyanin was measured after 24 hours to assure stationary phase for all
different isolates as seen in Fig 2A. The effect of 10× sub-MIC concentrations of the three anti-
biotics on the growth of the three bacteria strains was examined (Fig 2B). Overall, we found
that the three antibiotics did not affect growth for any of the strains when compared to growth
in the absence of the antibiotics (Paired t-tests; Ps> 0.05; S2 Table). This result enabled us to
compare pyocyanin production directly between the different treatments. Different strains of
the bacteria are expected to produce different levels of exopolysaccharides and secreted pro-
teins, influencing turbidity, viscosity and growth rate of the individual strains. Therefore, we
corrected the pyocyanin concentrations for optical density (OD600 nm) (Fig 3). We found that
eight out of ten environmental strains produce significantly elevated levels of pyocyanin com-
pared to PAO1 (F(10, 37) = 3.421; P = 0.0030; Fig 3). More specifically, we found that strain
Pae110 and Pae113 produced the highest amount of pyocyanin with 14.6 (3.15) μM/OD600 nm
and 15.72 (4.8) μM/OD600 nm, respectively. On the other hand, we found that strain Pae160
only produce a modest amount of pyocyanin, 3.49 (1.88) μM/OD600 nm, while strain Pae111
barely produced detectable amounts of pyocyanin, 0.03 (0.14) μM/OD600 nm. Optical density
was considered for normalization of all the proceeding data.
Exposure to antibiotic sub-MIC concentrations influences the production
of pyocyanin
We investigated the potential impact of sub-inhibitory concentrations of antibiotics on viru-
lence activity on three strains. PAO1 was selected as the reference strain and as a producer of
Fig 2. P. aeruginosa growth curves when exposed to sub-MIC antibiotic concentrations. (a) Growth curves of the 10
environmental strains showing stationary phase after 24 hours of growth under shaking in 37˚C in lysogeny broth. (b)
Evaluation of the effect of concentrations of ciprofloxacin (Cipro), tobramycin (Tobra), and meropenem (Mero) at 10x
sub-MIC values on the growth of strains. Statistical analysis revealed non-significant changes in presence of low antibiotic
concentrations for the tested strains (paired t-test, Ps>0.05). Means ± SEM are presented and estimated from 4 replicates.
https://doi.org/10.1371/journal.pone.0248014.g002
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low pyocyanin concentrations, while Pae85 was selected as a producer of high pyocyanin pro-
duction and Pae112 was a producer of medium level concentrations compared to the other
environmental strains we screened. The pyocyanin production of these strains were measured
after exposure to 10× sub-MIC concentrations of ciprofloxacin, tobramycin, and meropenem,
respectively.
We compared the changes of pyocyanin production affected by individual antibiotic treat-
ment in all three strains with that of an untreated control. We then investigated the effect of
one antibiotic, independently of the other two treatments for each strain using paired t-test
and the data are presented in Fig 4A–4C. Individual analysis for each strain and treatment
reveal that changes in pyocyanin production can be detected in Pae85 for sub-MIC concentra-
tions of ciprofloxacin (t(2) = 4.663, P = 0.043, Fig 4A and Pae112 for tobramycin (t(2) = 6.354,
P = 0.0239, Fig 4B and meropenem (t(2) = 13.63, P = 0.0053, Fig 4C. Our results suggest that
the effect of sub-inhibitory concentrations of different antibiotics can have singular effect on
different bacterial strains.
Pyocyanin affects virulence impact on host cells
The observed increase in pyocyanin production as a result of sub-MIC antibiotic exposure has
a virulent impact on hosts cells. This was demonstrated by comparing the effect of a concentra-
tion series of pure pyocyanin and supernatant extracted from a PA01 culture on the viability of
a monolayer of HaCaT cells. While pyocyanin extract tested for the direct effect of the mole-
cule on virulence, the PAO1 supernatant includes other molecules in addition to pyocyanin.
Interestingly, we found a similar dose-dependent toxic effect of both the PAO1 supernatant
and pyocyanin pure compounds (Paired t-test; t(2) = 2.12; Ps> 0.05; Fig 5A and 5B). This
Fig 3. Quantification of production of pyocyanin in environmental strains of P. aeruginosa and PAO1. P.
aeruginosa strains were grown in LB media at 37˚C, 180 rpm for 24 hours until stationary phase was reached. One-way
ANOVA multiple comparisons with Tuckey post hoc test (�Ps<0.05, ��Ps<0.007) reveals a significant difference in
pyocyanin production between the strains. Data showing normalization using maximum pyocyanin production in 10
environmental strains of P. aeruginosa and PAO1 (F (10,25) = 4.799, P = 0.0007). Data normalized using optical density
(OD600nm), means ± SD are presented and estimated from a minimum of three replicates.
https://doi.org/10.1371/journal.pone.0248014.g003
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result demonstrates the virulence activity of pyocyanin on HaCaT cells and shows that pyocya-
nin is most likely the main component of virulence in PAO1 supernatant.
Discussion and conclusion
Antibiotics are not always effective at killing all bacterial cells during infection. This is because
not all antibiotics have the same pharmacokinetic and pharmacodynamic properties. For
example, the antibiotics do not diffuse to all infection sites and bacterial biofilms can also pro-
vide a protective shield. This is important for several reasons. First, because it may lead to
recurring infections, appearance of resistant or persistent bacteria and second because we do
not fully understand the effects of sub-inhibitory antibiotic concentrations on bacterial patho-
genesis. P. aeruginosa virulence molecules have shown to have several physiological roles [31].
Fig 4. Pyocyanin quantification when strains exposed to sub-MIC antibiotic concentrations. Changes in pyocyanin levels in response to
treatment of 10x sub-MIC of (a) ciprofloxacin (Cipro), (b) tobramycin (Tobra), and (c) meropenem (Mero), tested on PA01, Pae85, and
Pae112. The changes in pyocyanin production are normalized using optical density (OD600 nm). Data from single strain analysis with
means ± SEM from 3 to 4 replicates (Paired t-test, �P<0.0332, ��P<0.0021).
https://doi.org/10.1371/journal.pone.0248014.g004
Fig 5. HaCaT toxicity. (a) Pyocyanin induced cell death in HaCaT cells, correlating percent cell viability with cell
metabolic activity. Two pyocyanin sources were tested, standard sample where commercially available pyocyanin was
used and supernatant, where PAO1 supernatant was tested and the corresponding concentrations are solely based on
pyocyanin quantification present. (b) Pyocyanin concentration which gives 50% cell death (EC50) are plotted from
three replicates with SD error bars for pyocyanin, in both standard and supernatant solutions, respectively. The
average values calculated are of 10.5 and 2.6 μM, and SD of 1.5 and 2.5, respectively. Paired t-test revealed no statistical
(ns) difference in toxicity between pyocyanin from standard and supernatant solutions.
https://doi.org/10.1371/journal.pone.0248014.g005
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However, due to challenges in quantifying these molecules, studies that report the effect of
antibiotic treatment on virulence molecule secretion have been limited. In this study, we assess
the effects of sub-inhibitory antibiotic concentrations on pyocyanin production through an
emerging electrochemical-based technique that allows rapid and direct measurements of the
virulence factor. This method allowed intensive high-throughput screenings of pyocyanin pro-
duced by P. aeruginosa strains under different antibiotics exposure. Moreover, this technique
allows on-the-spot measurements of pyocyanin, without the risk of chemical degradation, con-
centration loss due to purification methods, or time-consuming measurements.
Our results point out that different P. aeruginosa strains produce significantly varied pyo-
cyanin levels (Fig 3). This can translate into the ability of each strain to cause substantial toxic-
ity upon host invasion. When three different P. aeruginosa strains were challenged with low
antibiotic concentrations, the recorded levels showed different profiles (Fig 4). The differences
could be attributed to their different mode of action. Ciprofloxacin (fluoroquinolone) inhibits
DNA replication, tobramycin (aminoglycoside) inhibits protein synthesis and meropenem
(beta-lactam) inhibits cell wall synthesis. In PAO1 ciprofloxacin caused an increase of pyocya-
nin production, while with tobramycin treatment, the pyocyanin levels remained unchanged.
In contrast, the levels of the pyocyanin were significantly affected by this antibiotic in Pae112.
Our results not only demonstrate that low concentrations of antibiotics can affect the virulence
of bacterial strains but could also help identify future antimicrobial treatment in a clinical set-
ting. For example, our data shows that low concentration of meropenem decreased pyocyanin
levels in Pae112, indicating that this antibiotic could be a better choice in the clinic for the
treatment of P. aeruginosa infections.
Previous studies have also reported that the accumulation of pyocyanin [32] in P. aerugi-
nosa and that of other virulence factors [10] can enhance antibiotic tolerance. For this reason,
increased pyocyanin activity could be of particular importance for resistance development
especially for ciprofloxacin where resistance is present at a high level among clinical isolates
[8]. Future studies may investigate the effect of P. aeruginosa virulence in correlation with
resistance and tolerance profiles in response to ciprofloxacin and other antibiotics. Another
aspect of change of virulence levels in presence of low concentrations of antibiotics that could
be further explored is the combined effect of all three antibiotics and investigate whether the
antibiotic act in synergy. This is highly important as many P. aeruginosa infections are treated
simultaneously with a cocktail of antibiotics [33].
To conclude, as a proof-of-concept, we have demonstrated that sub-inhibitory concentra-
tions of specific antibiotics impact pyocyanin production in an important bacterial model sys-
tem. The main observation perceived from the present study is that if certain antibiotics do
not completely eradicate the bacteria, the insufficient antibiotic concentrations induce a bacte-
rial response in terms of virulence factor production. Future work should focus on determin-
ing why this is the case for some antibiotics and not others, how sub-inhibitory antibiotic
concentrations may affect the production of other virulence factors like alginate, pyochelin
and phenazines, and in which degree sub-inhibitory concentrations of antibiotics play a role
in refractory infections in vivo. While further investigations are needed, we can propose that
the effect of sub-MIC values on the virulence activity of bacteria is also a measure that is rele-
vant to screen for when designing antibiotic treatments for patients. This knowledge can be
another step towards more efficient patient treatment and antibiotic management.
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